Healthpeak Properties (NYSE:DOC) Updates FY 2026 Earnings Guidance

Healthpeak Properties (NYSE:DOC) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided EPS guidance of 1.730-1.770 for the period, compared to the consensus estimate of 1.750. The company issued revenue guidance of -.

Healthpeak Properties Stock Performance

Healthpeak Properties stock traded down $0.05 during mid-day trading on Tuesday, reaching $21.59. 7,269,111 shares of the company’s stock were exchanged, compared to its average volume of 8,640,407. The business’s fifty day simple moving average is $21.05 and its 200 day simple moving average is $18.70. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. Healthpeak Properties has a one year low of $15.70 and a one year high of $22.95. The firm has a market capitalization of $14.89 billion, a PE ratio of 67.48, a P/E/G ratio of 3.39 and a beta of 1.02.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings data on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.05. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The firm had revenue of $771.58 million during the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. On average, sell-side analysts expect that Healthpeak Properties will post 1.75 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a monthly dividend, which will be paid on Friday, September 25th. Investors of record on Monday, September 14th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) annualized dividend and a yield of 5.7%. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Wall Street Analyst Weigh In

Several brokerages have commented on DOC. Barclays began coverage on shares of Healthpeak Properties in a research report on Tuesday, July 7th. They issued an “equal weight” rating and a $23.00 price objective on the stock. Evercore lowered shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price target for the company. in a research note on Monday, May 11th. JPMorgan Chase & Co. lifted their price target on shares of Healthpeak Properties from $18.00 to $21.00 and gave the stock a “neutral” rating in a report on Wednesday, June 24th. Wall Street Zen raised Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Finally, BMO Capital Markets boosted their target price on Healthpeak Properties from $20.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, June 15th. Four research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $20.62.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.23% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Advocate Investing Services LLC purchased a new position in Healthpeak Properties during the 4th quarter valued at about $26,000. CYBER HORNET ETFs LLC bought a new position in shares of Healthpeak Properties in the second quarter valued at approximately $33,000. DV Equities LLC bought a new position in shares of Healthpeak Properties in the fourth quarter valued at approximately $36,000. Wiser Advisor Group LLC purchased a new position in Healthpeak Properties during the third quarter valued at approximately $38,000. Finally, Los Angeles Capital Management LLC bought a new stake in Healthpeak Properties during the 4th quarter worth approximately $55,000. Institutional investors own 93.57% of the company’s stock.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.